HER2+ Therapy: Getting Less Toxic All the Time
Drs Kathy Miller and Clifford Hudis discuss at SABCS 2014 recent advances in HER2+ breast cancer, focusing on the growing interest in lowering the toxicity of therapy. (Source: Medscape Oncology)
Source: Medscape Oncology - December 22, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
SOFT Yields Hard Data on Hormone Therapy
Drs Kathy Miller and Ann Partridge drill down on the practice-changing data from the SOFT trial, indicating which breast cancer patients should receive ovarian suppression. (Source: Medscape Oncology)
Source: Medscape Oncology - December 22, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
TNT Refines Platinum Use in TNBC
Drs Kathy Miller and Andrew Tutt discuss the findings of the important TNT trial, which indicates the significance of knowing BRCA status in using platinums for triple-negative breast cancer. (Source: Medscape Oncology)
Source: Medscape Oncology - December 22, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Screening Men With a Family History of Prostate Cancer
Men with a family history of prostate cancer may be more likely to have prostate cancer themselves, but do they benefit from the screening process? Dr Gerald Chodak discusses the latest research. (Source: Medscape Oncology)
Source: Medscape Oncology - December 18, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
The Future of Hodgkin Lymphoma -- Brentuximab and Beyond
Dr Bruce Cheson and Dr Ann LaCasce highlight data from ASH 2014 on brentuximab vedotin and discuss promising agents for Hodgkin lymphoma, including checkpoint inhibitors nivolumab and pembrolizumab. (Source: Medscape Oncology)
Source: Medscape Oncology - December 18, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
CLL: It's the Best -- and Most Confusing -- of Times
Dr Bruce Cheson and Dr Susan O'Brien discuss data presented at the 2014 ASH meeting on chronic lymphocytic leukemia, with a focus on the CLL10 trial as well as ibrutinib, idelalisib, and ADT-199. (Source: Medscape Oncology)
Source: Medscape Oncology - December 17, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Double-Hit Lymphomas Explained, With Surprising EPOCH-R Data
Dr Bruce Cheson and Dr Andrew Zelenetz define 'double-hit' lymphomas and discuss trial results for these hard-to-treat patients, as well as other promising agents in lymphoma. (Source: Medscape Oncology)
Source: Medscape Oncology - December 16, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
R-squared Update: Underwhelms in FL, but Impressive in MCL
Dr Bruce Cheson and Dr Nathan Fowler discuss lenalidomide clinical trial results at the 2014 ASH meeting, focusing on a trial presented by the Nordic Lymphoma Group. (Source: Medscape Oncology)
Source: Medscape Oncology - December 15, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Should GPs Refer More Patients for Cancer Tests?
The National Institute for Health and Care Excellence released symptom-based referral guidelines with a predictive value of < 3%. David Kerr questions the impact that it will have on cancer survival. (Source: Medscape Oncology)
Source: Medscape Oncology - December 15, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
How to Use Molecular Tumor Boards to Defeat Cancer
Dr Lundberg explains how the Human Genome Project has transformed tumor boards in ways that can only benefit patients with intractable cancers. (Source: Medscape Oncology)
Source: Medscape Oncology - December 12, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Canadians Advance Discussion Over PSA Screening
Dr Gerald Chodak goes beyond the headlines to examine the new Canadian guidelines for PSA screening. (Source: Medscape Oncology)
Source: Medscape Oncology - December 4, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
SOFT Trial Landing at SABCS
Dr Kathy Miller's preview of SABCS 2014 spotlights key data in triple-negative, HER2+, and local-regional disease as well as the much-anticipated results from the SOFT trial. (Source: Medscape Oncology)
Source: Medscape Oncology - December 1, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Immuno Death Ray to GI Cancers
Can immunotherapy 'clip the force field' of gastrointestinal tumors? Dr John Marshall and experts say yes and will discuss advances during the Ruesch Symposium 2014, December 5, Washington, DC. (Source: Medscape Oncology)
Source: Medscape Oncology - November 25, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
ASH 2014: If You're Going to San Francisco…
Dr Bruce Cheson previews important data being presented at the upcoming ASH 2014 meeting, including studies of CLL, Hodgkin lymphoma, and the role of interim PET scans in large cell lymphoma. (Source: Medscape Oncology)
Source: Medscape Oncology - November 25, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
How Safe Is Chemotherapy in Pregnancy?
Dr David Kerr reports on a study comparing the pharmacokinetics of doxorubicin and taxanes in pregnant and nonpregnant women, suggesting that anthracyclines should be recommended over taxanes. (Source: Medscape Oncology)
Source: Medscape Oncology - November 13, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
